Question explored with the scientific record
How many times should someone have blood tests when taking Lithium
The short version: lithium is a narrow-window drug, and the monitoring schedule matters less than never skipping a check.
The evidence here is thin and mostly old. One 1992 study found patients averaged about 5 lithium level checks per year, with hospital patients checked slightly more often than GP patients [1]. That is a description of what doctors did, not proof of what works. The same study found three serious toxicity cases, including one patient who went four years without any check [1]. That alone tells you the real risk: not checking at all.
The bigger concern is kidney damage. A 2001 cohort found long-term lithium patients lost kidney concentrating ability over time [2]. A 2018 review recommends checking serum creatinine and eGFR every 3 to 6 months, plus lithium levels [6]. A 2026 meta-analysis found lithium users had lower eGFR than non-users, though the CKD risk evidence was messy and possibly confounded [7]. Thyroid is also a real issue: hypothyroidism prevalence runs as high as 47%, with a 5:1 female-to-male ratio [5]. One case report showed lithium-induced hypothyroidism masquerading as depression [4].
The practical answer: get a lithium level at least every 3 months, and kidney function (creatinine/eGFR) at the same time. Thyroid (TSH) at least yearly. More often if you have kidney disease, take diuretics, are elderly, or feel unwell. Toxicity can appear even at mildly elevated levels [8], and chronic toxicity is worse than acute [3].
My call: check lithium and kidney function every 3 months, thyroid yearly, and immediately if symptoms appear. Confidence: moderate.
Sources used 8
-
Lithium treatment: prescribing and monitoring habits in hospital and general practice.
A prospective observational study in Edinburgh/Midlothian comparing lithium prescribing and monitoring between hospital outpatient care and general practice, revealing substantial variation in dosing frequency and serum monitoring with several safety concerns and a call for stan…
DOI: 10.1136/bmj.304.6826.552 -
A historical cohort study of kidney damage in long-term lithium patients: continued surveillance needed
This retrospective cohort study followed 149 long-term lithium patients (8–12 years after initial renal assessment) to quantify changes in renal concentrating ability (Umax) and glomerular filtration rate (GFR), finding that renal dysfunction increases with lithium treatment dur…
DOI: 10.1016/s0924-9338(01)00565-x -
Implication of serum concentration monitoring in patients with lithium intoxication
In 78 patients with lithium intoxication, acute intoxication usually caused mild symptoms even at high serum levels, whereas chronic intoxication more often caused severe symptoms, and no patient died or had persistent neurological sequelae.
DOI: 10.1111/j.1440-1819.2004.01188.x -
Identifying depression secondary to lithium-induced hypothyroidism
A detailed case report showing that a bipolar patient on long-term lithium developed subclinical hypothyroidism presenting as depression; serial TRH testing revealed an exaggerated TSH response that normalized with thyroid hormone replacement, underscoring the need to evaluate t…
DOI: 10.1016/s0033-3182(84)72949-5 -
Lithium: a review of its metabolic adverse effects
Lithium treatment is associated with metabolic adverse effects, including hypothyroidism, hyperparathyroidism, weight gain, and nephrogenic diabetes insipidus; their mechanisms are incompletely understood and monitoring is recommended.
DOI: 10.1177/0269881105057515 -
Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification
A narrative literature review synthesizing evidence on lithium-associated nephrotoxicity, its risks, clinical management, and risk stratification to guide decisions for long-term lithium therapy in bipolar disorder.
DOI: 10.1186/s12882-018-1101-4 -
Lithium nephrotoxicity: a systematic review and meta-analysis of lithium versus non-lithium control studies in patients with affective disorders
Systematic review and meta-analysis finds lithium use in affective disorders is associated with lower eGFR and higher serum creatinine compared with non-lithium controls, but CKD risk evidence is highly heterogeneous and may reflect confounding rather than true lithium-induced n…
DOI: 10.1177/20451253261419633 -
Unrecognized acute lithium toxicity: a case report
A 63-year-old man on chronic lithium, maprotiline and haloperidol developed unrecognized lithium toxicity (1.46 mmol/L) with severe renal insufficiency and neurological symptoms, recovering fully after 10 hemodialyses. Acknowledging the access to the PDF is limited; the extracti…
DOI: 10.2478/s11536-012-0058-0